Page last updated: 2024-12-08
10,16-dihydroxyhexadecanoic acid
Description
## 10,16-Dihydroxyhexadecanoic Acid: A Fatty Acid with Research Potential
10,16-Dihydroxyhexadecanoic acid (10,16-DHDA) is a long-chain fatty acid with two hydroxyl groups located at the 10th and 16th carbon positions. It is a naturally occurring compound found in various organisms, including bacteria, fungi, and plants.
**Why is it important for research?**
10,16-DHDA has attracted significant research interest due to its diverse biological activities and potential applications in various fields, including:
**1. Antibacterial and Antifungal Properties:**
* Studies have shown that 10,16-DHDA exhibits potent antibacterial activity against Gram-positive bacteria, including Staphylococcus aureus and Streptococcus pneumoniae.
* It also displays antifungal activity against various fungal species, including Candida albicans.
* This makes 10,16-DHDA a potential candidate for developing new antimicrobial agents to combat antibiotic-resistant infections.
**2. Anti-inflammatory Effects:**
* 10,16-DHDA has been shown to possess anti-inflammatory properties in various experimental models.
* It inhibits the production of pro-inflammatory cytokines like TNF-α and IL-6, reducing inflammation and potentially mitigating inflammatory diseases.
**3. Modulation of Cell Signaling:**
* 10,16-DHDA can interact with cell membrane receptors and influence cell signaling pathways.
* Research is ongoing to explore its potential role in regulating cell growth, differentiation, and apoptosis.
**4. Potential in Cosmetic Applications:**
* Due to its moisturizing and skin-soothing properties, 10,16-DHDA is being investigated for its potential use in cosmetics and skincare products.
**5. Biomarker for Health Conditions:**
* 10,16-DHDA levels have been found to vary in specific health conditions.
* Further research is needed to investigate its potential as a biomarker for diseases like cancer and diabetes.
**Current Research and Future Directions:**
* Researchers are actively investigating the mechanisms of action of 10,16-DHDA to understand its biological effects better.
* Further studies are needed to evaluate its safety and efficacy in preclinical and clinical settings.
* Efforts are underway to develop synthetic or biotechnological methods for producing 10,16-DHDA on a larger scale for potential pharmaceutical and cosmetic applications.
**Overall, 10,16-dihydroxyhexadecanoic acid is a promising compound with diverse biological activities and potential applications in medicine, cosmetics, and other fields. Ongoing research continues to unravel its therapeutic potential and broaden its applications for human health and well-being.**
10,16-dihydroxyhexadecanoic acid: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 441449 |
CHEBI ID | 692 |
SCHEMBL ID | 2459399 |
MeSH ID | M0450075 |
Synonyms (11)
Synonym |
10,16-dihydroxy-palmitic acid |
LMFA01050341 |
10,16-dihydroxy-hexadecanoic acid |
hexadecanoic acid, 10,16-dihydroxy- |
C08285 |
3233-90-7 |
10,16-dihydroxyhexadecanoic acid |
SCHEMBL2459399 |
CHEBI:692 |
Q27105328 |
DTXSID10954121 |
Drug Classes (1)
Class | Description |
hydroxy fatty acid | Any fatty acid carrying one or more hydroxy substituents. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 13.26
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 13.26 (24.57) | Research Supply Index | 1.95 (2.92) | Research Growth Index | 5.21 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |